Fig. 2: Longitudinal Therapeutic Responses in Individuals with and without Relapse.
From: Immunotherapy responsiveness and risk of relapse in Down syndrome regression disorder
Clinical features, including behavioral and neuropsychiatric assessments over the study period for patients with and without neurologic relapse.
